Liver resection for hepatocellular carcinoma in patients with hematological malignancies

BACKGROUND: Improvements in antimetabolite drugs have prolonged the survival of patient with hematological malignancies. However, these drugs may have hepatotoxic side effects and may induce acute liver failure, chronic liver fibrosis, cirrhosis, or even hepatocellular carcinoma (HCC). Although live...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Surg Oncol
Main Authors: Lin, Hui-Chen, Yang, Yang-Shen, Teng, Chieh-Lin Jerry, Shen, Ching-Hui, Jan, Yee-Gee, Cheng, Shao-Bin, Wu, Cheng-Chung, Lin, Yi-Ling, Huang, Chu-Chun, P’eng, Fang-Ku
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5667519/
https://ncbi.nlm.nih.gov/pubmed/29096656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-017-1260-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados